Additional file 1: Table S1. of Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications

IMRT target volume definitions and dose prescription. Table S2. Dosimetric patterns of failure. (DOCX 16 kb

Additional file 2: of Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

Figure S1. Patient number 10 who had a PR with a tumor regression of 47% on the combination of pembrolizumab and lenvatinib continues to have a response at the time of data analysis. Axial post contrast CT images through the chest demonstrates right lower lobe pulmonary nodule (red arrow) and pleural based left lower lobe nodularity (yellow arrow) on baseline scan(A) with treatment response on subsequent follow up imaging at 5 months (B) and 8 months (C). (PDF 256 kb

Additional file 1: Table S1. of Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old

Proportions of patients reporting moderate to severe (≥5) rating for the 22 MDASI-HN symptom items by clinical subgroups of interest. (DOCX 20 kb